Researchers from the United Kingdom have published their views on the inclusion of pregnant women in clinical trials for vaccines against the novel coronavirus and the related challenges this presents. Their article titled, “Inclusion of pregnant women in COVID-19 vaccine development”, was published yesterday in The Lancet Infectious Diseases.
Researchers Paul T Heath and Kirsty Le Doare, from Pediatric Infectious Diseases Research Group and Vaccine Institute, Institute of Infection and Immunity, St. George’s University of London, worked with Asma Khalil from Vascular Biology Research Centre, Molecular and Clinical Sciences Research Institute, St. George’s University of London to write this review piece with the available evidence.
